Akiram Therapeutics announced that it has raised SEK 68 million in a round of funding led by new investor Sciety AB on January 12, 2023. The transaction included participation from new investor Linc AB invested SEK 20 million through shares.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
67.4 SEK | +2.28% | +3.69% | +4.33% |
Apr. 22 | Linc AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Jan. 25 | Linc AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+4.33% | 348M | |
+1.78% | 140M |
- Stock Market
- Equities
- LINC Stock
- News Linc AB
- Akiram Therapeutics AB announced that it has received SEK 68 million in funding from Sciety AB, Linc AB